4//SEC Filing
Revance Therapeutics, Inc. 4
Accession 0001209191-16-103573
CIK 0001479290operating
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 8:47 PM ET
Size
6.3 KB
Accession
0001209191-16-103573
Insider Transaction Report
Form 4
BYRNES ROBERT F
Director
Transactions
- Gift
Common Stock
2016-02-24−10,999→ 0 total - Gift
Common Stock
2016-02-24+10,999→ 13,665 total(indirect: By Trust)
Footnotes (1)
- [F1]Represents transfer of shares to the Mr. Byrnes' Family Trust. Mr. Byrnes continues to beneficially own such shares through indirect ownership through The Byrnes Family Trust.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 8:47 PM ET
- Size
- 6.3 KB